Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioglan
Malmö, Skåne, Swedenbioglan.se ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Bioglan AB is a GMP- and ISO 13485-certified CDMO with 40+ years' experience, offering end-to-end development, analytics, and clinical/preclinical manufacturing of topical and semi-solid pharmaceuticals and medical devices.
- Therapeutic areas
- ImmunologyNeurologyDermatologyOther
- Modalities
- Semi-solid dosage forms (e.g., creams, gels, ointments, lotions)Small moleculeBiologic (for topical applications)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Partnerships with pharmaceutical and medtech companies for topical manufacturing and formulation development (names not publicly listed)
Beyond the preview
Go deeper on Bioglan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bioglan.